Dupuytren Contracture Management Update

Stephanie Russo, MD, PhD; C. Liam Dwyer, MD

Dupuytren disease affects approximately four percent to six percent of the U.S. population. It is much more common in males than females, and prevalence increases with age. Myofibroblasts are central to the pathologic changes that occur with the disease, and the cords are thought to form in response to mechanical stress. The condition was originally described in the 1600s, and treatment recommendations in the late 1700s–1800s included percutaneous and open fasciotomy.

Second Look – Clinical News and Views

These items originally appeared in AAOS Headline News Now, a thrice-weekly enewsletter that keeps AAOS members up to date on clinical, socioeconomic, and political issues, with links to more detailed information. Subscribe at www.aaos.org/news/news.asp (member login required).

Success Story: Managing Bone Health

Dudley A. Phipps, PA-C, CCD; Kevin Ward; Craig R. Mahoney, MD

One in two women in the United States over the age of 50 will experience an osteoporosis-related fracture in their lifetime. And as the population continues to age, the number of these fractures will likely grow, further burdening our country’s healthcare system. Historically, some local healthcare systems and communities have not focused on osteoporosis. Therefore, efficient diagnosis and treatment are not offered.

The Rules for Opioid Prescribing in 2018

Eeric Truumees, MD

In the March issue of AAOS Now, frustrated by my own ignorance of the web of conflicting laws and regulations around opioid prescribing, I offered a framework to better understand our roles as orthopaedic surgeons. With this column, I’d like to explore the “real-world” risks of ill-considered prescribing and some best practices to mitigate those risks.